News

Abiomed’s Impella percutaneous left ventricular assist device (pLVAD) was recently deployed at Baylor Medical Center in McKinney, Texas, to treat country music singer Randy Travis.

Home July 11, 2013
Home
News

Sudden cardiac death (SCD) is the leading cause of death in high school-aged athletes. To determine if SCD can be prevented with a heart screening, The Christ Hospital Health Network (Cincinnati, Ohio), The University of Mississippi Medical Center and Cincinnati Children’s Hospital Medical Center partnered with USRowing and Toshiba America Medical Systems Inc. to conduct The Athlete Heart Research Study. Initial participants included volunteer high school rowers with more than two years of continuous practice who competed in the USRowing Youth National Championships, June 7 – 9, 2013 in Oak Ridge, Tenn.

Home July 11, 2013
Home
Clinical Study JAMA Percutaneous Coronary Interventions Angiography
Feature

In a clinical study that included nearly 6 million Medicare Advantage and Medicare fee-for-service beneficiaries from 12 states, rates of angiography and percutaneous coronary interventions were significantly lower among Medicare Advantage beneficiaries and geographic variation in procedure rates was substantial for both payment type. The study was published in the July 10 issue of JAMA.

Home July 11, 2013
Home
News

Researchers have announced the results of a five-year study that shows early fetal echocardiography provides reliable prenatal diagnosis of major congenital heart disease (CHD). First trimester screening looks very promising for detection of heart problems and increases the need for scheduling early and detailed cardiac evaluations.

Home July 10, 2013
Home
News

Epsilon Imaging Inc. announced a clinical study demonstrating EchoInsight for Cardio Oncology to be a high quality, efficient application for comprehensive assessment of left ventricle (LV) function. The study, presented at the ASE 2013 Scientific Sessions in Minneapolis, Minn., further indicated EchoInsight for Cardio Oncology facilitates monitoring of patients at risk for cardiotoxicity. EchoInsight for Cardio Oncology is a vendor neutral application designed to assist clinicians in improving confidence and workflow of study interpretation and reporting when monitoring oncology patients.

Home July 10, 2013
Home
News

Researchers have announced the results of a retrospective five-year study, which shows that echocardiography can be useful in identifying new strategies for combating the growth failure in infants with hypoplastic left heart syndrome (HLHS). The high mortality and morbidity rate for these high-risk infants with congenital cardiac anomalies has been difficult to change, but this is a promising step for medical intervention.

Home July 10, 2013
Home
Technology

Sectra has recently registered a new Class 1 software medical device, Sectra DoseTrack, with the U.S. Food and Drug Administration (FDA).

Home July 09, 2013
Home
News

Researchers have announced the results of a study which shows that among patients readmitted for congestive heart failure (CHF), a high E/e’ (a measure of elevated left ventricle filling pressure via ultrasound) at admission is significantly associated with higher 30-day readmission rates. Focusing on lowering elevated E/e’ levels will be important to control healthcare costs and to reduce the high rates of morbidity and mortality in this patient population.

Home July 09, 2013
Home
Medical Imaging U.S. Healthcare Overtesting New England Journal of Medicine
Feature

Big changes are coming to the U.S. healthcare system — some in response to the mounting scrutiny of medical imaging. New task force recommendations, the Choosing Wisely campaign and Affordable Care Act policies are all attempting to curtail overtesting — with computed tomography (CT) scans, magnetic resonance imaging (MRI) and any other screening often ordered unnecessarily — that can drive up medical costs, lead to waste and unnecessary radiation, and prompt undue anxiety about false positive results.

Home July 09, 2013
Home
Feature

Researchers have announced the results of a clinical study that shows a key difference in the patient’s baseline heart size and function following transcatheter valve replacement (TAVR) that may help predict their medical outcomes. Previous work by these researchers showed that even mild paravalvular aortic regurgitation (PAR), detected by echocardiograms performed on these patients, appears to correlate with increased mortality. The current study revealed that certain baseline characteristics found on the echocardiograms could help predict which patients were more likely to have PAR.

Home July 09, 2013
Home
Technology

Philips Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its AlluraClarity live image guidance system in the United States.

Home July 08, 2013
Home
News

North Shore University Hospital (NSUH) announced it has installed the most advanced cardiac computed tomography (CT) scanner to help diagnose heart disease and a patient’s risk for heart attack.

Home July 08, 2013
Home
Technology

AirStrip announced the first phase of its strategic participation in Microsoft’s AppsForSurface program. As part of the program, the company will launch and make available AirStrip ONE Cardiology not only on Windows 8.1-enabled mobile devices, but also on laptops and desktops.

Home July 08, 2013
Home
FDA US device innovation
Feature | Anita Asgar, M.D., FSCAI

With recent medical device advances have come increasing concerns about the ability of the United States to remain at the forefront of research, especially in light of stringent FDA policies regarding clinical trials and device approval. This concern was the subject of keynote addresses by Jeffrey Popma and Robert (Chip) Hance at the 2013 SCAI Scientific Sessions.

Home July 03, 2013
Home
cath lab, SYNTAX, SCAI
Feature | Dmitriy N. Feldman, M.D., FACC, FSCAI

The year 2013 has brought us several important clinical trials that have changed the way interventional cardiologists approach and treat patients with stable coronary artery disease. These trials were a major focus at the “Hottest Topics 2013” session at the Society for Cardiovascular Angiography and Interventions (SCAI) 2013 Scientific Sessions

Home July 03, 2013
Home
Subscribe Now